Kestra Medical Technologies, Ltd. Investing Cash Flow
Kestra Medical Technologies, Ltd. (KMTS) reported Investing Cash Flow of -$21.35 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-09-14
- Kestra Medical Technologies, Ltd. net cash provided by (used in) investing activities for the quarter ending 2026-07-31 was -$21.35M.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) investing activities for the quarter ending 2026-04-30 was -$172.71M.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) investing activities for the quarter ending 2026-01-31 was -$14.92M.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) investing activities for the quarter ending 2025-10-31 was -$7.42M.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) investing activities for fiscal 2026 was -$203.28M.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) investing activities for fiscal 2025 was -$23.31M.
- Kestra Medical Technologies, Ltd. net cash provided by (used in) investing activities for fiscal 2024 was -$12.23M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-07-31 | -$21.35M 10-Q · filed 2026-09-14 | -$194.06M derived: sum of 2 quarters · filed 2026-09-14 | -$208.98M derived: sum of 3 quarters · filed 2026-09-14 | -$216.40M derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | -$172.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | -$187.63M derived: sum of 2 quarters · filed 2026-07-14 | -$195.04M derived: sum of 3 quarters · filed 2026-07-14 | -$203.28M 10-K · filed 2026-07-14 |
| 2026-01-31 | -$14.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | -$22.34M derived: sum of 2 quarters · filed 2026-03-17 | -$30.57M 10-Q · filed 2026-03-17 | -$37.98M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | -$7.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | -$15.65M 10-Q · filed 2025-12-11 | -$23.06M derived: sum of 3 quarters · filed 2026-09-14 | -$27.51M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | -$8.23M 10-Q · filed 2026-09-14 | -$15.64M derived: sum of 2 quarters · filed 2026-09-14 | -$20.09M derived: sum of 3 quarters · filed 2026-09-14 | -$24.51M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | -$7.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | -$11.85M derived: sum of 2 quarters · filed 2026-07-14 | -$16.27M derived: sum of 3 quarters · filed 2026-07-14 | -$23.31M 10-K · filed 2026-07-14 |
| 2025-01-31 | -$4.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | -$8.87M derived: sum of 2 quarters · filed 2026-03-17 | -$15.90M 10-Q · filed 2026-03-17 | |
| 2024-10-31 | -$4.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-11 | -$11.45M 10-Q · filed 2025-12-11 | ||
| 2024-07-31 | -$7.03M 10-Q · filed 2025-09-12 | |||
| 2024-04-30 | -$12.23M 10-K · filed 2025-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |